On July 16, Intuitive Surgical fell 3.32% in after-hours trading, trading at $375.44/share, with turnover of $68.14 million. The stock reversed its earlier intraday gain of 3.16% after the company released its second-quarter earnings report following the market close.

The after-hours pullback came despite strong pre-earnings momentum, as the medical device sector had rallied broadly during regular trading, with Abbott up 12.7%, Stryker up 5.81%, and Boston Scientific up 5.23%. The company maintained its full-year global da Vinci procedure volume growth guidance at approximately 13.5% to 15.5%, expecting the actual figure to land near the midpoint of that range. For context, Q1 revenue had grown 23% year-over-year to $2.77 billion, with adjusted EPS of $2.50 both exceeding expectations. Multiple investment banks had recently lowered their price targets ahead of earnings, with BTIG cutting to $512 from $574 and RBC reducing to $600 from $650, though both maintained positive ratings.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)